Research Blog – INTERNAL USE ONLY

TJX 4Q20 Earnings

Key Takeaways:

1.       Beat driven by higher than expected same store sales of +6% (vs street +3.2% and guidance of +2%-3%).

2.       They had strong SSS results across all segments with particular strength in TJX International (Europe/Australia) demonstrating continued share gains. SSS int’l were +10% vs. cons 3.6%.

3.       Guidance light, but seems conservative.

4.       They have seen no impact from Coronavirus and say it’s too soon to predict any impact. They do not directly source a significant amount of goods from China.  

 

Current Price:    $64                        Price Target: Raising to $70 from $65

Position Size:    3.7%                      TTM Performance: 20%

 

 

Highlights:

·         TJX reported a strong quarter beating on sales and EPS. 4Q EPS of $0.81 vs. cons. of $0.77 and guidance of $0.74-$0.76

·         Earnings guidance light, but seems conservative. Both Q1 and FY2021 guidance was slightly below the street, but mgmt. tends to guide conservatively.  

·         FY2021 guided to EPS of $2.77 to $2.83 per share vs street $2.86 w/ SSS guidance of  with comps of 2%-3% vs. consensus of 3%.

·         1Q guided to EPS of $0.59-$0.60 vs cons. of $0.61, with comps of 2%-3% versus cons. of. 3.1%,

·         They tend to guide conservatively, with EPS and revenue beating consensus 18 of the last 21 quarters

·         Traffic was again the biggest driver of SSS. The fact they continue to grow traffic while many peers are seeing the opposite, validates that their concept is resonating w/ consumers and is a promising indicator for future SSS. E-commerce sales are not included in SSS numbers.

·         Marmaxx (their largest segment) – comp sales increased 6%, lapping a very strong 7% increase last year.

·         International again had the strongest SSS of +10% – they continue to take share despite a tough retail environment in Europe.

·         GM were better than expected on “significantly” higher merchandise margins but somewhat offset by higher SG&A.

·         They now have over 4,500 stores, including more than 1,200 outside of the United States.

·         They continue to see excellent inventory availability

·         Chart below demonstrates TJX’s resistance to e-commerce and economic cycles. Despite the ramp in e-commerce share of retail over the last several years, of the companies listed below TJX is nearly half of aggregate incremental spend. The companies listed below represent more than 2/3 of the ~$275B in US apparel retail sales. Additionally, in the ’08 to ’09 period they were one of few retailers that continued to grow and post positive SSS.

[more]

 

 

Valuation:

·         Balance sheet is strong. They have no net debt.

·         Store openings will bolster top line growth.

·         They have been steadily FCF positive, even through the financial crisis they posted 3% FCF margins. LT FCF margins are ~7%.

·         Valuation is reasonable at >4% forward yield.

The Thesis on TJX:

·         Market leader: opportunity to benefit from a lasting paradigm shift in consumer frugality. Treasure hunters – TJX has strong brands that attract cost conscious consumers– evident through consistently strong customer traffic.

·         Strong bargaining power with suppliers due to size.

·         Quality: Solid and consistent execution and top line growth driving strong margins through cost cutting/inventory control.

·         Shareholder returns: Strong returns, balance sheet and cash flows being used for share buyback program, dividend, and store expansion.

 

$TJX.US

[tag TJX]

[category earnings]

 

Sarah Kanwal

Equity Analyst, Director

 

Direct: 617.226.0022

Fax: 617.523.8118

 

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

 

 

 

DIS CEO Stepping down

Disney just announced that Bob Iger is stepping down as CEO, effective immediately. Bob Chapek has been named the new CEO – he has been at Disney for 27 years and most recently served as Chairman of Disney Parks, Experiences and Products. Iger has been CEO for over 15 years and was expected to remain CEO until the end of 2021. While the timing was a surprise, Iger will stay on and assume the role of Executive Chairman and “will direct the Company’s creative endeavors,” while leading the Board through the end of his contract on Dec. 31, 2021. Mr. Chapek will report to Iger, and the Board of Directors. He will be appointed to the Board at a later date.  In terms of timing, Iger said the purpose of handing over the CEO role now was to turn over day-to-day management in order to free him up to focus all his time on the creative side. Chapek is 60 years old and is signing a contract for just three years.

 

 

 

Sarah Kanwal

Equity Analyst, Director

 

Direct: 617.226.0022

Fax: 617.523.8118

 

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

 

$DIS.US

[category equity research]

[tag DIS]

 

TIREX – Q4 2019 Commentary

TIREX Commentary – Q4 2019

Thesis

TIREX utilizes fundamental research to find properties in high barrier markets, with higher occupancy and rent growth. By focusing on quality companies and avoiding unnecessary risks, the fund obtains a strong track record that has outperformed the benchmark and REIT ETF over time. We continue to hold TIREX because of the team’s growth focus with asset concentrations in supply constrained markets. Lastly, TIREX was the lowest cost active manager screened, at 51bps.

 

Continue reading “TIREX – Q4 2019 Commentary”

HLMEX – Q4 2019 Commentary

HLMEX Commentary – Q4 2019

Thesis

HLMEX utilizes fundamental research to find companies with strong quality and growth metrics that can be compared across the global landscape. By focusing on investments with competitive advantages, long-term growth potential, quality management, and corporate strength, HLMEX offers diversity to our EM allocation while generating alpha over the long run. We continue to hold the fund because of the team’s conviction in high quality companies and managed risk through diversification and evaluation.

 

Continue reading “HLMEX – Q4 2019 Commentary”

BEXIX – Q4 2019 Commentary

BEXIX Commentary – Q4 2019

Thesis

BEXIX is driven through bottom-up fundamental research that provides diversification within our full EM allocation. The fund looks for growth companies across all market caps that have a sustainable competitive advantage. We like BEXIX because the team takes advantage of companies that focus on consumer business and technological advancements, helping the fund produce returns above the benchmark (MSCI Emerging Markets Index).

 

Continue reading “BEXIX – Q4 2019 Commentary”

LISIX – Q4 2019 Commentary

LISIX Commentary – Q4 2019

Thesis

LISIX is a bottom-up, growth-based fund that completes the core satellite strategy within global equity. The fund is unique in that it focuses on individual stocks rather than markets and looks for reasonably priced companies with strong growth potential. We like LISIX because of the managers’ expertise in various market caps, geographies, and sectors which helps keep the fund diversified while providing strong upside and downside capture over time.

 

Continue reading “LISIX – Q4 2019 Commentary”

HILIX – Q4 2019 Commentary

HILIX Commentary – Q4 2019

Thesis

Serving as a satellite holding, HILIX is a value style fund that takes advantage names that have underperformed recently and are cheaply priced. The team generates alpha by finding companies with strong fundamentals that are overlooked during times of low consensus expectations. We like that HILIX takes advantage of extremes and gains exposure to less efficient market caps by having more holdings and moderate active bets.

 

Continue reading “HILIX – Q4 2019 Commentary”

JPIN – Q4 2019 Commentary

JPIN Commentary – Q4 2019

Thesis

JPIN’s focus on risk weighting enabled us to replace a market cap weighted index while still gaining exposure to international developed equity markets without deviating too far from the benchmark. Utilizing a multi-factor approach of value, quality, and momentum, JPIN has generated alpha through strong stock selection over time. Additionally, the fund helps diversify risk by weighting across 40 regional/sector buckets based on rolling risk statistics, which ultimately increases our exposure to active share and our risk-adjusted returns.

 

Continue reading “JPIN – Q4 2019 Commentary”

Fairfax Q4 2019 results

On 2/13, Fairfax Financial posted solid earnings for Q4 2019 of $23.58 well ahead of street estimates of $15.89.

Key takeaways:

1.       President retires – Fairfax’ President, Paul Rivett, has retired.  Chairman and CEO, Prem Wasta, has resumed control of operations. 

2.       Solid insurance results – Company grew book value at 14.8%, indicated a favorable new business environment with organic growth of 13% and posted a healthy combined ratio of 96.9%.

3.       Improved investment results – Investments added $1.7b during 2019

Continue reading “Fairfax Q4 2019 results”

TCPNX – Q4 2019 Commentary

TCPNX Commentary – Q4 2019

Thesis

TCPNX is a smaller fund that does not have as many assets under management compared to our other core mangers, enabling them to make more nimble and tactical decisions. By making small allocations to undervalued “riskier” asset classes (high-yield and non-dollar denominated debt), TCPNX diversifies our fixed income portfolio and generates superior returns to the benchmark (Barclays U.S. AGG). We like that the fund utilizes a bottom-up investment process through proprietary framework analysis, fundamental security review, and portfolio risk management.

 

Continue reading “TCPNX – Q4 2019 Commentary”